New patent expiration for Novartis drug EXFORGE

Annual Drug Patent Expirations for EXFORGE Exforge is a drug marketed by Novartis and is included in two NDAs. It is available from three suppliers. There are four patents protecting…

The post New patent expiration for Novartis drug EXFORGE appeared first on DrugPatentWatch.


Comments are closed.

Biotechblog